# SINGULAIR

NDC: 78206-171
Generic name: montelukast sodium
Labeler / Manufacturer: Organon LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: GRANULE
Routes: ORAL
Marketing started: 20210601

FDA application: NDA021409

## Active ingredients

- MONTELUKAST SODIUM: 4 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"78206-171"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=78206-171
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=482dcc92-b47f-4ea6-854a-f5ac2aea7842